COPB1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.119000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.939400E-01
Normal-vs-Stage2
7.786800E-01
Normal-vs-Stage3
3.767800E-01
Normal-vs-Stage4
2.961000E-01
Stage1-vs-Stage2
9.901200E-01
Stage1-vs-Stage3
3.234800E-01
Stage1-vs-Stage4
4.394200E-01
Stage2-vs-Stage3
2.627600E-01
Stage2-vs-Stage4
3.560800E-01
Stage3-vs-Stage4
9.261600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.213600E-01
Normal-vs-AfricanAmerican
5.131800E-01
Normal-vs-Asian
7.510400E-01
Caucasian-vs-AfricanAmerican
4.921000E-01
Caucasian-vs-Asian
3.385400E-01
AfricanAmerican-vs-Asian
2.132200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.686200E-01
Normal-vs-Female
8.740200E-01
Male-vs-Female
4.552800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.999600E-01
Normal-vs-Age(41-60Yrs)
4.881800E-01
Normal-vs-Age(61-80Yrs)
9.834400E-01
Normal-vs-Age(81-100Yrs)
9.519800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.625000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.756400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.282200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.618300E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.423200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.517800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.987400E-01
Normal-vs-Daily Drinker
4.691800E-01
Normal-vs-Weekly Drinker
6.589000E-01
Normal-vs-Occasional Drinker
4.099400E-01
Normal-vs-Social Drinker
5.910000E-01
Non Drinker-vs-Daily Drinker
1.934230E-01
Non Drinker-vs-Weekly Drinker
5.591000E-01
Non Drinker-vs-Occasional Drinker
3.082000E-02
Non Drinker-vs-Social Drinker
2.107800E-01
Daily Drinker-vs-Weekly Drinker
5.893800E-01
Daily Drinker-vs-Occasional Drinker
4.715200E-03
Daily Drinker-vs-Social Drinker
2.768300E-02
Weekly Drinker-vs-Occasional Drinker
3.536400E-02
Weekly Drinker-vs-Social Drinker
1.147560E-01
Occasional Drinker-vs-Social Drinker
3.821200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.070800E-01
Normal-vs-Grade 2
1.327790E-01
Normal-vs-Grade 3
6.816400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.070400E-01
Grade 1-vs-Grade 3
3.783700E-02
Grade 1-vs-Grade 4
3.070800E-01
Grade 2-vs-Grade 3
5.196000E-01
Grade 2-vs-Grade 4
1.327790E-01
Grade 3-vs-Grade 4
6.816400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.149000E-01
Normal-vs-NonDiabetic
9.191000E-01
Diabetic-vs-NonDiabetic
5.284600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.299600E-01
Normal-vs-NoPancreatitis
9.005200E-01
Pancreatitis-vs-NoPancreatitis
7.204000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.531800E-01
Normal-vs-N1
7.984600E-01
N0-vs-N1
9.060600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.417600E-01
Normal-vs-TP53-NonMutant
8.511000E-01
TP53-Mutant-vs-TP53-NonMutant
2.428400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
